24-11-2025 20:15 via medpagetoday.com

New Moms' GLP-1 Prescriptions Jumped After Wegovy Approval

(MedPage Today) -- Prescriptions for GLP-1 receptor agonists increased among postpartum women once semaglutide (Ozempic, Wegovy) was approved for weight loss, a Danish epidemiological study found.
In the first quarter of 2018, there were less...
Read more »

Medical Industry news



Defying death: The origins of ageing
Trump administration slashes Ozempic and Wegovy price for Medicare
More Benefits With Coffee, This Time in People With Severe Mental Disorders
Untreated Chronic Thyroid Dysfunction in Moms Tied to Autism in Kids
A White House Plan to Extend Obamacare Subsidies Runs Into Familiar GOP Divisions
Some Older Adults Could Use an RSV Booster Shot, Study Suggests
Mom Charged in Ketoacidosis Death; 15-Day CGM Launches Soon; Long-Acting GLP-1 Win
Can Calorie Restriction Slow Brain Aging? 5 Human Brain Epochs; Anti-Tau Drug Fails
After 5 Years, Acid-Reducer Is Back on the Market
FDA Gives Broad Approval to Gene Therapy for Rare Neurologic Disease
Popular Heart Burn Drugs Linked to Worse Survival in Another Cancer Type
Using Minimal Residual Disease for DLBCL Response Assessment
Where Metabolic Surgery Fits Into the MASH Treatment Landscape
Nurses, Healthcare Groups Up in Arms Over Trump's Student Loan Plan
Desktop versie